Event related oscillations in euthymic patients with bipolar disorder

Neuroscience Letters

Volumn 444, Issue 1, 2008, Pages 5-10

  Özerdem, Ayşegül ^a   Kocaaslan, Sibel ^a   Tunca, Zeliha ^a   Başar, Erol ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ISTANBUL KULTUR UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Delta responses; Event related oscillations; GABA glutamate; Neurocognitive functioning; Neuroprotection; Valproate

Indexed keywords

VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DRUG BLOOD LEVEL; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; FRONTAL CORTEX; GABAERGIC TRANSMISSION; HUMAN; MALE; MONOTHERAPY; NEUROPROTECTION; OSCILLATION; PRIORITY JOURNAL; TEMPORAL CORTEX; VISUAL STIMULATION;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; BRAIN MAPPING; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; VALPROIC ACID;

EID: 50849110818     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.07.081     Document Type: Article

References (43)

1. Ö. Aydemir, A. Deveci, Validity and Reliability of Structured Interview for Hamilton Depression Rating Scale Seasonal Affective Disorders Version. VIIth Annual Spring Symposium of Psychiatric Association of Turkiye Abstract book, 2003, p. 187.
2. The Evoked potential manifests a superposition of event-related oscillations. In: Başar E. (Ed). Brain Function and Oscillations. Volume I. Brain Oscillations. Principles and Approaches (1998), Springer-Verlag, Berlin Heidelberg 269
3. Basar E., Basar-Eroglu C., Karakas S., and Schurmann M. Are cognitive processes manifested in event-related gamma, alpha, theta and delta oscillations in the EEG. Neurosci. Lett. 259 (1999) 165-168
4. Basar E., Basar-Eroglu C., Karakas S., Schurmann M., and Gamma. Alpha, delta and theta oscillations govern cognitive processes. Int. J. Psychophysiol. 39 (2001) 241-248
5. Basar-Eroglu C., Basar E., Demiralp T., and Schurmann M. P300 response: possible psychphysiological correlates in delta and theta frequency channels: a review. Int. J. Psychophysiol. 13 (1992) 161-179
6. Berettini W.H., Nurnberger Jr. J.I., Hare T.A., Simmons-Alling S., Gershon E.S., and Post R.M. Reduced plasma and CSF gamma-aminotbutyric acid in affective illness: effect of lithium carrbonate. Biol. Psychiatry 18 (1983) 185-194
7. Berettini W.H., Nurnberger Jr. J.I., Hare T.A., Simmons-Alling S., and Gershon E.S. CSF GABA in euthymic manic-depressive patients and controls. Biol. Psychiatry 21 (1986) 844-846
8. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., and Cowen P.J. Reduction in occipital cortex γ-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry 61 (2007) 806-812
9. Blumberg H.P., Leung H.C., Skudlarski P., Lacadies B.S., Fredericks C.A., Harris B.C., Charney D.S., Gore J.C., Krystall J.H., and Peterson B.S. A functional magnetic resonance imaging study of bipolar disorder state and trait-related dysfunction in ventral prefrontal cortices. Arch. Gen. Psychiatry 60 (2003) 601-609
10. Bowden C.L. Valproate Bipolar Disord. 5 (2003) 189-202
11. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 8 (2003) 721-737
12. Bruder G.E., Stewart J.W., Towey J.P., Fredman D., Tekne C.E., Voglmaier M.M., Leite P., Cohen P., and Quitkin F.M. Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings. Biol. Psychiatry 32 (1992) 3-47
13. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., and Manji H.K. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72 (1999) 879-882
14. Clark L., Iversen S.D., and Goodwin G.M. Sustained attention deficit in bipolar disorder. Br. J. Psychiatry 180 (2002) 313-319
15. Diagnostic Statistical Manual of Mental Disorders, Fourth Ed., American Psychiatric Press Inc., Washington, D.C. 1994.
16. El-Badri S.M., Ashton C.H., Moore P.B., Mursh V.R., and Ferrier I.N. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord. 3 (2001) 79-87
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV) (1996), American Psychiatric Press Inc., Washington, D.C.
18. Gobbi D., and Debonnel G. What is recommended treatment for aggression in a patient with schizophrenia?. J. Psychiatry Neurosci. 28 (2003) 320
19. Gobbi G., and Janiri L. Sodium and magnesium - valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology 185 (2006) 25-262
20. Guidotti A., Auta J., Davis J.M., DiGiorgi Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., and Costa E. Decrease in reeling and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 57 (2000) 1061-1069
21. Heckers S., Stone D., Walsh J., Shick J., Koul P., and Benes F. Differential expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59 (2002) 521-529
22. Kaiya H., Namba M., Yoshida H., and Nakamura S. Plasma glutamate decaroxylase activity in neuropsychiatry. Psychiatry Res. 6 (1982) 335-343
23. Karadaǧ F., Oral E.T., Yalçi{dotless}n F.A., Eten E., and Validity. Reliability of young mania rating scale in Turkey. Turk. J. Psychiatry (Turk Psikiyatri Derg. ) 13 (2002) 107-114
24. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goddard A., Mason G.F., and Glutmate. GABA systems as targets for novel antidepressant and mood-stablizing treatments. Mol. Psychiatry 7 (2002) S71-S80
25. Löscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16 (2002) 669-694
26. Martinez-Aran A., Vieta E., Colom F., Torrent C., Sanchez-Moreno J., Reinares M., Benabarre A., Goikolea J.M., Brugue E., Daban C., and Salamero M. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 6 (2004) 224-232
27. Michael N., Erfurth A., Ohrmann P., Gössling M., Arolt V., Heindel W., and Pfleiderer B. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 168 (2003) 344-346
28. Muir W.J., St.Clair D.M., and Blackwood D.H.R. Long latency auditory event-related potentials in schizophrenia and in bipolar and unipolar affective disorder. Psychol. Med. 21 (1991) 867-879
29. O'Donnell B.F., Hetrick W.P., Vohs J.L., Drishnan P., Carroll C.A., and Shekha A. Neuronal synchronization deificits to auditory stimulation in bipolar disorder. Neuroreport 15 (2004) 1369-1372
30. O'Donnell B.F., Vohs J.L., Hetrick W.P., Carroll C.A., and Shekhar A. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. Int. J. Psychophysiol. 53 (2004) 45-55
31. Petty F. GABA and mood disorders: a brief review and hypothesis. J. Affect. Disord. 34 (1995) 275-281
32. Post R.M., Putnam F., Contel N.R., and Goldman B. Electroconvulsive seizures inhibit amygdala kindling: implications for mechanism of action affective illness. Epilepsia 25 (1984) 234-239
33. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 4 (2002) 105-116
34. Salisbury D.F., Shenton M.E., Sherwood A.R., Fischer I.A., Yurgelun-Todd D.A., Tohen M., and McCarley R.W. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch. Gen. Psychiatry 55 (1998) 173-180
35. Salisbury D.F., Shenton M.E., and McCarley R.W. P300 topography differs in schizophrenia and manic depressive psychosis. Biol. Psychiatry 45 (1999) 98-106
36. Savitz J., Solms M., and Ramesar R. Neuropsycholgical dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord. 7 (2005) 216-235
37. Souza V.B.N., Muir W.J., Walker M.T., Glabus M.S., Roxeborouh H.M., Sharp C.W., Dunan J.R., and Blackwood D.H.R. Auditory P300 event related potential and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol. Psychiatry 37 (1995) 300-310
38. Starkstein S.E., and Robinson R.G. Mechanism of disinhibition after brain lesions. J. Nerv. Ment. Dis. 185 (1997) 108-114
39. Strakowski S.M., Akler C.M., Holland S.K., DelBello M.P., and Eliassen J.C. Abnormal fMRI Brain Activation in euthymic bipolar disorder patients during a counting Stroop interference task. Am. J. Psychiatry 162 (2005) 1697-1705
40. Strakowski S.M., DelBello M.P., and Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol. Psychiatry 10 (2005) 105-116
41. Wilder-Willis K.E., Sax K.W., Rosenberg H.L., Fleck D.E., Shear P.K., and Strakowski S.M. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord. 3 (2001) 58-62
42. Xiaohua L., Ketter T.A., and Frye M.A. Synaptic, intracellular, and neuroprotective mechanism of anticonvulsants: are they relevant for the treatment and course of bipolar disorder?. J. Affect. Disord. 69 (2002) 1-14
43. Zarate C.A., Du J., Quiroz J., Gray N.A., Denicoff K.D., Singh J., Charney D.S., and Manji H.K. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of glutamatergic system. Ann. NY Acad. Sci. 1003 (2003) 273-291